JulieJisunPaikMDMHS
Rheumatology • Baltimore, MDMyositis, Scleroderma & Related
Associate Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Paik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5501 Hopkins Bayview Circle
Baltimore, MD 21224Phone+1 443-997-1552Fax+1 410-550-1033
Summary
- Dr. Julie Paik is a rheumatologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. She received her medical degree from George Washington University School of Medicine and has been in practice 11 years. She also speaks multiple languages, including Korean. She specializes in myositis and scleroderma & related.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2010 - 2013
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2006 - 2009
George Washington University School of Medicine and Health SciencesClass of 2006
Certifications & Licensure
CA State Medical License 2007 - Present
FL State Medical License 2020 - Present
MD State Medical License 2013 - 2025
NH State Medical License 2024 - 2024
VA State Medical License 2023 - 2024
NC State Medical License 2020 - 2022
OK State Medical License 2020 - 2021- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Study of Tofacitinib in Refractory Dermatomyositis Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Fact...Christopher A Mecoli, David Fiorentino, Jemima Albayda, Julie J Paik, Eleni Tiniakou
ACR Open Rheumatology. 2024-12-01 - A protocol for scoping reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammator...Mickael Essouma, Daniel Brito de Araujo, Jessica Day, Edoardo Conticini, Mary Anne Riopel
Rheumatology International. 2024-11-01 - Response to: Correspondence on 'Current myositis clinical trials and tribulations' by Saygin.Didem Saygin, Victoria Werth, Julie J Paik, Jin Kyun Park, Merrilee Needham
Annals of the Rheumatic Diseases. 2024-10-21
Press Mentions
Most RMD Patients Retain Antibodies 6 Months After COVID-19 VaccinationFebruary 14th, 2022- COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among ImmunocompromisedNovember 22nd, 2021
- Researchers Describe First Reports of Breakthrough COVID Infections, Booster Shots in Rheumatology PatientsSeptember 13th, 2021
- Join now to see all
Other Languages
- Korean
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/julie-paik
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
